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Introduction
Alcohol based hand rubs (ABHRs) are extremely effec-
tive at reducing microbial contamination and are central
to established best practices for hand hygiene. Modern
dispensing systems have brought benefits such as hygie-
nically sealed cartridges with integral pumps for dosing
liquids, gels or foams. A remaining issue concerns the
measured efficacy of such products and their use in
practice as dictated by pump volume.
Objectives
ABHRs for professional use must demonstrate efficacy
through standard in-vivo tests; either EN1500 or ASTM
E1174. Products typically pass such tests using standard
doses not necessarily related to real use by healthcare
workers. In this study we set out to identify the optimal
dose for an ABHR product based on observation of real
behavior.
Methods
Data from the DebMed GMS Hand Hygiene Monitoring
System was used to establish product dose applied in
clinical settings via the number of dispenser presses per
hand hygiene event. In a separate study healthcare
workers applied ABHR using best-practice methodology
to establish product drying time as a function of dose.
Hand coverage was assessed using a laboratory method
based on product coverage. In-vivo efficacy was estab-
lished using both ASTM E1174 and EN 1500 methods.
Results
Healthcare workers intuitively calibrate ABHR dose
based on drying time, hand coverage and product ergo-
nomics. In our studies using Deb dispensers, over 90%
of healthcare workers used a single pump of ABHR,
even when multiple pumps are indicated. Our studies
established that 1.5ml of ABHR in foam format dries in
approximately 30 seconds and fully covers most hands.
Both ASTM 1174 and EN 1500 tests confirmed that
1.5ml of Deb ABHR in foam format with 30 seconds
contact time was sufficient to provide effective hand
hygiene.
Conclusion
Product drying time, hand coverage and measured effi-
cacy data are considered to determine the optimal dose
for an ABHR in foam format dispensed from a sealed
cartridge wall-mounted unit. This is combined with
observed behaviour of healthcare workers to design a
pump that delivers the optimal dose in a single press,
connecting for the first time measured in-vivo efficacy
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